James Dowling is a seasoned professional in the field of medicinal chemistry with over two decades of experience. Currently serving as Senior Director of Medicinal Chemistry at Eli Lilly and Company since January 2025, James previously held key positions at AstraZeneca from 2008 to 2017, focusing on oncology drug discovery as an Associate Principal Scientist and Team Leader. Before that, James worked at Morphic Therapeutic from February 2023 to January 2025 and held various roles, including Senior Director and Director of Medicinal Chemistry. James began the career at Biogen Idec as a Scientist in small-molecule drug discovery from May 1999 to February 2006. James earned a Ph.D. in Chemistry from Princeton University and a Bachelor of Science in Chemistry from UMass Boston.
This person is not in any teams
This person is not in any offices